Loading
Latest filing published 02 Apr 2026 for 메디톡스.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
천영익, listed as board member, appears in our data through filings on 메디톡스 shares, published by DART (FSS). We count 2 filings; the first trade dates from 31 March 2022 and the latest from 27 March 2026.
Every open-market trade on record is a purchase: 2 purchases worth €144k, and no sale. The totals exclude 1 filing filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2026 alone, the filings show 1 purchase and no sales.
The latest filing, published on 2 April 2026, reports an open-market purchase in 메디톡스. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.